Stay updated with breaking news from Operations Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Net earnings were $477.7 million, or $0.46, per diluted share for the fourth quarter of fiscal 2022 compared with $563.9 million, or $0.52, per diluted share...
/PRNewswire/ -- U.S. Well Services, Inc. (the "Company", "USWS," "U.S. Well Services" or "we") (NASDAQ: USWS) today reported first quarter 2022 financial and...
Accelerated planning for next phase of development of Haduvio for the treatment of chronic cough in IPF based on results from statistically significant interim...
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...
Accelerated planning for next phase of development of Haduvio for the treatment of chronic cough in IPF based on results from statistically significant interim...